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Aminoacyl-tRNA synthetases produce aminoacyl-tRNAs, essential substrates for accurate protein
synthesis. Beyond their central role in translation some of these enzymes or their orthologs are
recruited for alternative functions, not always related to their primary cellular role. We investigate
here the enzymatic properties of GenX (also called PoxA and YjeA), an ortholog of bacterial class II
lysyl-tRNA synthetase. GenX is present in most Gram-negative bacteria and is homologous to the
catalytic core of lysyl-tRNA synthetase, but it lacks the amino terminal anticodon binding domain
of the latter enzyme. We show that, in agreement with its well-conserved lysine binding site, GenX
can activate in vitro L-lysine and lysine analogs, but does not acylate tRNALys or other cellular RNAs.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.Pro1. Introduction
Aminoacyl-tRNA synthetases (aaRSs) comprise a family of
enzymes whose primary function is the generation of aminoacyl-
tRNAs (aa-tRNAs) for protein synthesis. The aminoacylation
reaction is a two step process whereby the cognate amino acid is
ﬁrst activated to aminoacyl-AMP, and then esteriﬁed to the 30-ter-
minal adenosine of the corresponding tRNA molecule. The central
role of the aaRSs in ensuring accurate protein synthesis and hence
cell survival, as well as their contribution to the emergence of
modern days genetic code has been widely documented [1,2].
One of the outcomes of the broad genome sequencing effort was
the realization of the existence of many genes with sequence
homology to parts of known aaRSs [3]. While it was initially be-
lieved that these homologs may be pseudo-genes and remnants
of the complex aaRS evolutionary history [2,4], a closer look at
the enzymatic properties of the gene products proved this idea
wrong. While none of the known aaRS orthologs was able to trans-
fer an amino acid to the 30-end of a tRNA molecule, they neverthe-
less showed different enzymatic activities. For instance, a set of
small proteins present in bacteria and eukarya with sequence
homology to the editing domain of bacterial type prolyl-tRNA syn-
thetase were shown to hydrolyze the misacylated Ala-tRNAPro andchemical Societies. Published by E
f Molecular Biophysics and
hitney Avenue, New Haven,
brogelly).Cys-tRNA species [5]. Self-standing homologs of alanyl-tRNA
synthetase and threonyl-tRNA synthetase editing domains, present
in bacteria and archaea, also deacylate incorrectly charged aa-tRNA
species [5,6]. Another example was provided by the presence in
more than 40 bacterial genomes of a the YadB protein, displaying
homology to the catalytic core of glutamyl-tRNA synthetase
(GluRS), but lacking the whole anticodon binding domain. Like
GluRS, YadB activates glutamate in presence of ATP; in contrast
to GluRS, it transfers the activated glutamate onto the modiﬁed
nucleoside queosine, located at the ﬁrst position of the tRNAAsp
anticodon [7,8]. Aminoacyl-tRNA synthetase analogs have also
been recruited for non-tRNA related functions such as amino acid
biosynthesis. The HisZ protein with signiﬁcant similarity to HisRS
but lacking an anticodon binding domain and residues essential
for catalysis was shown to be present in Lactococcus lactis and a
number of other bacterial species [12]. While this protein is unable
to activate histidine, it participates together with the HisG protein
in the ﬁrst step of histidine biosynthesis in these organisms [9].
Likewise, an asparginyl-tRNA synthetase homolog with a truncated
anticodon binding domain is found in Pyrococcus abyssi and in a
number of archaea. In these organisms, in absence of the expected
characterized asparagine biosynthetic genes, this protein is
responsible for the production of asparagine [10]. The analysis of
bacterial genomes reveals the presence of GenX, a lysyl-tRNA syn-
thetase (LysRS) ortholog. While the existence of this protein has
been reported before [11], no function or activity is known. Thus,
we undertook the investigation of its biochemical properties.lsevier B.V. All rights reserved.
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2.1. General
Uniformly labeled [14C]lysine (78 Ci/mmol), sodium [32P]pyro-
phosphate (15 Ci/mmol) were from Amersham Biosciences. L-ly-
sine and lysine analogs were purchased from Sigma. The
genX::Kan Escherichia coli knockout strain as well as the parental
wild type strain K-12 BW25113 was kindly sent by H. Mori Labo-
ratory (Keio University, Yamagata, Japan). E. coli LysRS was puriﬁed
as previously described [12].
2.2. Cloning of E. coli genX (yjeA)
E. coli genomic DNA was extracted from E. coli W3110 strain.
E. coli GenX encoding gene was ampliﬁed from corresponding
genomic DNA under standard PCR conditions using the following
primers Forward: (NdeI) 50-CATATGAGCGAAACGGCATCCTGG, and
Reverse: (BamHI) 50-GGATCCTTATGCCCGGTCAACGCTAAAG; the
ampliﬁed fragment was cloned into Topo TA (Invitrogen) vector
and transformed into Top 10 E. coli cells. The internal NdeI restric-
tion site in genX was removed by site-directed mutagenesis using
Qiagen quick-change technology. genX was sequenced prior to
sub-cloning into Pet15b (Invitrogen) expression vector.
2.3. Overexpression and puriﬁcation of GenX
E. coli BL21(DE3) C+ transformants were grown in Luria broth
supplemented with ampicillin (100 lg/ml) at 37 C to an optical
density at 600 nm of 1.0. The expression of the recombinant
protein was then induced by IPTG (isopropyl-b-D-thiogalactopyra-
noside, ﬁnal concentration of 1 mM) for 1 h at 37 C. Longer
over-expression times had a lethal effect on the host cells. The cells
were harvested by centrifugation and washed with phosphate buf-
fered saline; this and subsequent steps were performed at 4 C. The
cell paste was resuspended into lysis buffer (50 mM Tris–HCl, pH
8.0, 500 mM NaCl, 5 mM 2-mercaptoethanol, protease inhibitor
(Roche) and sonicated for 10 cycles of 30 s. The cell extract was
obtained by ultracentrifugation at 100 000g for 45 min and
subsequently applied to a Ni-nitrilotriacetic acid agarose column
(Qiagen), according to the standard procedure. The protein was
eluted with an elution buffer (containing 50 mM Tris–HCl [pH
8.0] and 750 mM imidazole), and loaded onto a PD-10 desalting
column (Amersham Bioscience) equilibrated in exchange Buffer A
(100 mM Tris–HCl, pH 8.0, 50 mM KCl, 25 mM MgCl2, 5 mM 2-
mercaptoethanol, 5% glycerol). The protein sample was then
loaded onto a 1 ml Mono-Q column (Amersham Bioscience). The
protein containing fractions were loaded onto a PD-10 desalting
column equilibrated in exchange Buffer B (100 mM Hepes-Na, pH
7.2, 50 mM KCl, 25 mM MgCl2, 5 mM 2-mercaptoethanol, 5% glyc-
erol) and subsequently loaded onto a 1 ml Mono-S column (Amer-
sham Bioscience). The puriﬁed proteins samples were then
dialyzed against storage buffer (100 mM Tris–HCl pH 8.0, 50 mM
KCl, 5 mM 2-mercaptoethanol, 50% glycerol) and then stored at
20 C. The purity of GenX recombinant enzyme preparation was
judged to be 99% by sodium dodecyl sulfate–polyacrylamide gel
electrophoresis followed by staining with Coomassie brilliant blue.
2.4. ATP-[32P]PPi exchange reaction
The reaction mixture of 0.2 ml contained 100 mM Tris–HCl, pH
8.0, 10 mMMgCl2, 50 mM KCl, 5 mM 2-mercaptoethanol, 2 mM KF,
ATP concentration either ﬁxed at 2 mM or varying from 0.1 to
10 mM for KM determination, L-lysine concentration ﬁxed at
10 mM or varying from 1 to 50 mM for KM determinations, 2 mM[32P]PPi (1.6 cpm/pmol) and 500 nM GenX protein. After various
incubation times at 37 C, the [32P]ATP present in 40 lL aliquots
of the reaction mixture was speciﬁcally adsorbed on acid-washed
Norit [0.2 ml of a 1%(w/v) in 0.4 M sodium pyrophosphate solution
with 15% (v/v) perchloric acid], rinsed with 15 ml of water on
Whatman GF/C ﬁber glass ﬁlter disks, dried, and liquid scintilla-
tion-counted. Effect of Mg2+ on L-lysine activation by GenX was
investigated by varying the concentration in MgCl2 from 0 to
10 mM in the reaction buffer. Likewise, L-lysine activation pH
optimum was determined by changing the nature of the reaction
buffer and its pH (Citrate–Na [pH 4.0 and 5.0], BisTris–HCl [pH
6.0 and 6.5], Hepes–Na [pH 7.2 and 7.5], Tris–HCl [pH 8.0 and
8.8], Glycine [pH 9.0 and 10.0] and CAPS [pH 11.0] while maintain-
ing the buffer concentration to 100 mM in all cases. The L-lysine
activation temperature optimum was determined in the standard
conditions by varying reaction temperature from 25 to 65 C.
2.5. Aminoacylation assay
In vitro acylations with E. coli GenX and LysRS enzymes were
carried out at 37 C in a 120 ll reaction mixture containing
100 mM Tris–HCl, pH 8.0, 10 mM MgCl2, 50 mM KCl, 5 mM 2-
mercaptoethanol, 2 mM ATP, 25 lM radioactive amino acid
[14C]lysine, and 40–60 lg of unfractionated tRNA or 0.7–1.3 lg of
pure tRNALys (Sigma). Enzyme concentration was 500 nM (genX)
or 100 nM (LysRS). Aliquots (20 ll) were taken at different times,
spotted on Whatman 3MM ﬁlter paper discs, and washed twice
with 5% TCA.
3. Results
3.1. GenX is a bacterial class II LysRS ortholog
Analysis of bacterial genomes revealed the presence of two dis-
tinctive types of class II LysRS orthologs. The ﬁrst one, termed LysX,
is restricted to organisms from the Actinobacteria group [13]. To
date it is found in nine organisms including all four sequenced
mycobacterial species. LysX is a fusion protein between a protein
homologous to a class II LysRS (38% homology and 41% similarity
to E. coli LysRS) and a polypeptide that shows homology to MprF
(23% identity and 42% similarity to S. aureus MprF), a membrane
protein known to transfer lysine to phospholipids in Gram-positive
bacteria [14]. The domain with sequence homology to MprF is ap-
pended to the amino terminus of the LysRS-like protein. The sec-
ond LysRS ortholog, known as GenX, PoxA or YjeA, is widespread
among Gram-negative bacteria since homologs can be found in
about 40 organisms, mostly in gamma proteobacteria (except for
the Pseudomonadaceae group), in organisms from the alpha and
delta proteobacteria, as well as in two human pathogens from
the spirochaetales group (Treponema pallidum and Leptospira inter-
rogans). GenX is a well-conserved protein of 326 amino acids (in
E. coli), which shows extensive sequence homology (31% identity
and 51% homology) to the LysRS class II catalytic core but appears
to be missing the well-characterized OB-fold anticodon binding
domain of the class II LysRS, which is localized at the amino termi-
nus of the polypeptide. Sequence alignment comparison of GenX
with E. coli LysRS, shows also almost complete conservation of
the active site amino acids involved in L-lysine and ATP binding
as identiﬁed by the crystal structure determination of the E. coli
LysRS and conﬁrmed by mutagenesis analysis (Fig. 1 and
[15,16]). Amino acids shown to be crucial for lysine binding by Lys-
RS (E240, R262, E278, Y280, E428 and N424) are strictly conserved
amongst GenX homologs (Fig. 1). Likewise, amino acids involved in
ATP binding and recognition (E264, E414, E421 and E480) are
conserved in the GenX active site (Fig. 1). Only G216, involved in
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the GenX active site (Fig. 1). Furthermore, a ﬁve amino acid
replacement in GenX (compared to LysRS) is clearly noticeable
immediately after motif 1. Based on these observations we cloned
E. coli genX, puriﬁed the corresponding gene product, and analyzed
its enzymatic properties.
3.2. GenX activates L-lysine
ATP-[32P]PPi exchange experiments with the pure recombinant
GenX shows that the protein is able to activate L-lysine in the pres-
ence of ATP (Fig. 2A). Determination of the kinetic parameters in
the ATP-PPi exchange reaction shows that GenX has a lower afﬁn-
ity for L-lysine (6.2 mM) than its full-length LysRS counterpart
(45 lM, reported in [12] and [16]). The afﬁnity for ATP was how-
ever similar for both enzymes: 200 lM for GenX and 50 lM and
227 lM for E. coli and Bacillus stearothermophilus LysRSs respec-
tively ([12] and [17]). ATP is most likely the natural substrate for
this enzyme since no activity was detected in the presence of the
other three nucleotides. GenX is a slower enzyme than its LysRS
counterpart since we found the turnover constant to be 0.9 s1
while published data for the LysRS range from 25 to 60 s1 ([12]Fig. 1. Sequence alignment of GenX from various bacterial species (Styphi, Ecoli, Ypest,
Yersinia pestis, Haemophilus inﬂuenzae, Sinorhizobium meliloti, Leptospira interrogans). Ecoli
are indicated. Residues involved in ATP and lysine binding are indicated by an open circ
Fig. 2. GenX activates L-lysine in vitro (A) in a magnesium concentration manner (B). (A)
10 mM lysine and either 2 mM ATP (j) or a mix of CTP/GTP/UTP (2 mM each,h) and in th
ATP (N) or a mix of CTP/GTP/UTP (2 mM each,4). Lysine activation of E. coli LysRS in the p
presence of 2 mM ATP and 10 mM (j), 5 mM (N), 1 mM (), 0.5 mM (d) and 0 mM (s)and [16]). We also found that like LysRS, GenX requires the pres-
ence of magnesium ions to be able to activate lysine (Fig. 2B). In or-
der to optimize the lysine activation we varied the pH and
temperature conditions. We found that the GenX activity was the
most robust at pH 8.0 and at temperatures ranging from 25 to
37 C.
3.3. GenX activates L-lysine analogs
The use of cognate amino acid analogs either as substrate or
inhibitor of the activation reaction has allowed mapping of the
topology of the active site of a number of aminoacyl-tRNA synthe-
tases. Extensive analysis of the way L-lysine analogs are recognized
by E. coli LysRS has been conducted recently ([16] and [18]). The
same approach had been used earlier to characterize B. stearother-
mophilus LysRS active site [19]. Using the same set of analogs we
investigated GenX amino acid recognition pattern (Fig. 3). We
found marked difference between the two enzymes. E. coli LysRS
readily activates S-(2-aminoethyl)-L-cysteine (AEC), ornithine, L-ly-
sine methyl ester and to a lesser extend lysine analogs such as D-
lysine, 5(R)-hydroxy-L-lysine and aminobutyric acid (Fig. 3). GenX
has a much narrower substrate spectrum since only 5(R)-hydroxy-Hinf, Smeli, Lint, refers to the following organisms: Salmonella typhimurium, E. coli,
S refers to the E. coli LysRS (encoded by lysS). Class II AARS deﬁning motifs I, II and III
le and a star respectively.
amino acid activation reaction catalyzed by GenX was performed in the presence of
e presence of a 19 amino acids mix (1 mM each, deprived of lysine) and either 2 mM
resence of ATP was used as control (s). (B) Lysine (10 mM) activation by GenX in the
magnesium chloride.
Fig. 3. Activation of L-lysine and L-lysine analogs. (A) Bar graph representing the activation of S-2 aminoethyl L-cysteine (1), L-lysine hydroxamide (2), lysinamide (3), 1–5
diaminopentane (4), ornithine (5), L-lysine methyl ester (6), D-lysine (7), 5-hydroxy L-lysine (8), alpha-aminobutyric acid (9), gamma-aminobutyric acid (10), diaminopimelic
acid (11) and L-lysine (K), all present at 25 mM concentration by E. coli LysRS (black bars) and GenX (grey bars). (B) molecular structure of L-lysine and 5-hydroxy L-lysine
(drawn with chemdraw-3D).
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droxy-L-lysine showed kinetic parameters sensibly similar to ones
found for L-lysine. In terms of inhibition of lysine activation, GenX
was the most efﬁciently inhibited by L-lysine hydroxamate and
lysinamide with Ki values of 150 and 280 lM respectively. These
two L-lysine analogs are also among the best E. coli LysRS inhibitors
[18].
5(R)-hydroxy-L-lysine is mostly found in eukarya and is not a
common metabolite in bacteria. We thus looked for other potential
L-lysine derivative present in bacteria. Diamino pimelic acid is the
direct precursor of lysine and an important component of the
bacterial cell wall peptidoglycan. Diaminopimelic acid could be
activated by GenX although to a lesser extent than L-lysine and
5(R)-hydroxy-L-lysine (Fig. 3). However, as for 5(R)-hydroxy-L-ly-
sine, diaminopimelic acid was a better substrate for GenX than
for E. coli LysRS (Fig. 3).
3.4. GenX does not transfer lysine onto RNA
While pure lysine tRNA and unfractionated tRNA extracted from
either wild type E. coli or the genX::Kan knockout strain could be
aminoacylated by E. coli LysRS, they were not substrate for GenX.
Total RNA extract also containing heavier molecular weight RNA
could not be lysylated by GenX either (data not shown).
4. Discussion
Evidence for the existence of GenX, also known as PoxA, was
ﬁrst reported in E. coli [11]. In this early work, an E. coli crude ex-
tract containing overexpressed recombinant GenX did not show
more lysine activation than an E. coli crude extract control contain-
ing only an empty vector, implying that the truncated LysRS was
unable to activate L-lysine [11]. We show here this is not the case
since a puriﬁed LysRS-free recombinant GenX protein preparation
is in fact able to activate L-lysine (Fig. 2). The lower afﬁnity for L-ly-
sine and lower catalytic turnover of GenX compared to LysRS may
explain the result observed earlier. Given the sequence similarity
between GenX and its LysRS counterpart, this dramatic difference
in substrate afﬁnity was initially surprising. Indeed, primary amino
acid sequence comparison indicates that all residues of LysRS
known to interact with lysine or ATP are conserved in GenX, except
for glycine 216 (E. coli LysRS numbering, Fig. 1). LysRS crystal struc-
tures captured at different stages during lysine activation indicate
that the oxygen of the amide peptide backbone of glycine 216
contacts the alpha amino group of the lysine substrate (Fig. 4A).These contacts are responsible for triggering a series of complex
active site conformational rearrangements [15]. Mutation of gly-
cine 216 to alanine in LysRS lowers dramatically the afﬁnity of
the mutant enzyme for L-lysine to 4.5 mM, an afﬁnity close to that
determined for GenX [16]. The absence of glycine 216 together
with a ﬁve amino acid replacement in the same region of the GenX
active site is therefore a likely reason for the lower afﬁnity for L-ly-
sine (Fig. 4B). The low turnover number (0.9 s1) of GenX when
compared to the value for LysRS may be a consequence of the lack
of the anticodon binding domain. The deletion of the B. stearother-
mophilus LysRS anticodon binding domain reduced the enzyme’s
kcat value 500-fold [19]; the kcat value decreased from 50 s1 for
the full length enzyme to 0.1 s1 for its truncated counterpart
[19]. The GenX turnover number is in line with that found for
the anticodon-truncated B. stearothermophilus LysRS, and thus con-
ﬁrms the role of the LysRS amino terminal anticodon binding do-
main in stabilizing the lysine activation transition state. Lastly,
the probing of the active site of GenX and LysRS using L-lysine
structural analogs conﬁrmed the notion of clear differences in
the active site topology of the two enzymes. The fact that diamino-
pimelic acid and 5-hydroxy lysine are good substrates for GenX,
but are not activated by the LysRS, suggests a more relaxed active
site for the truncated homolog.
While we now have established that GenX retains the ability to
activate L-lysine, its physiological role in a subset of bacteria re-
mains unclear. GenX has been linked to expression regulation of
pyruvate oxidase PoxB. Transposon insertion in genX was shown
to signiﬁcantly decrease PoxB expression in Salmonella typhimuri-
um and in E. coli [20]. Inactivation of genX was also shown to pro-
voke a severe attenuation of S. typhimurium virulence, making such
a strain a possible candidate for vaccine development [21]. An
E. coli GenX-inactivated mutant shows a pleiotropic phenotype, it
is more sensitive than the wild type counterpart to treatment with
antibiotics, a variety of amino acid analogs and dyes [20]. This pa-
per also shows that the inactivated E. coli mutant is more sensitive
to high concentrations of L-lysine than its wild type counterpart
(Supplementary Fig. 1). A recent report links GenX to the formation
of a post-translational modiﬁcation on elongation factor P (EF-P) in
bacteria [22]. In eukarya and archaea the EF-P homolog a con-
served lysine is modiﬁed to hypussine. This amino acid, essential
for EF-P function in organisms from the two aforementioned king-
doms, is absent in the bacterial EF-P homolog [22]. However, mass
spectrometric analysis of the E. coli EF-P showed that the protein is
modiﬁed at the homologous lysine with an unidentiﬁed structure
of 145 Da in mass [23]. The modiﬁcation of the EF-P lysine residue,
Fig. 4. Comparison of GenX (PDB code 3g1z, shown in tan) with the solved LysRS
structure (A) (PDB code: 1bbu shown in blue) shows three regions that are
structurally distinct. These include the complete absence of the N-terminal OB-fold
tRNA binding domain, and two loops in GenX (residues 49–53 and 272–279,
highlighted in yellow) that are adjacent to the active site. The lysyl-adenylate
binding pockets (B) are nearly identical in GenX and LysRS with the only exception
being residues located on the structurally distinct loop containing GenX residues
49–53 (yellow).
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attractive possibility [22]. The addition of hydroxy lysine, for in-
stance, would increase the mass of EF-P by 146 Da, a number in
line with experimental measurement. The chemical nature of the
modiﬁcation carried by EF-P in bacteria would differ form that of
its archaeal and eukaryotic counterparts. Hypussine is a secondary
amine where the epsilon amino group of lysine carries an amino
hydroxybutyl chain. The bacterial modiﬁcation would be formed
by the coupling of lysine epsilon amine to the carbonyl group of
a lysine analog via an amide linkage. Establishment of an amide
linkage (or the structurally equivalent ester) between an activated
amino acid and an acceptor moiety is common in bacteria. Acti-
vated amino acids have been shown to be transferred onto protein[24], nucleic acid [7], phospholipids [25] or other metabolites [26].
Hypussine exposes a positively charged amine to the surface of the
eukaryotic EF-P molecule, mediating interaction with the ribo-
some. Modiﬁcation of the bacterial EF-P with a lysine analog will
also result in exposure of primary amine to the surface of the elon-
gation factor, suggesting that both modiﬁcations could serve the
same functional purpose [23].
While a GenX involvement in EF-P modiﬁcation is an appealing
suggestion, experimental proof will be needed for its biogenesis
and its function in the cell.Acknowledgment
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